Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Lamotriginin HSA Conjugate

<strong>Lamotriginin HSA Conjugate</strong> <strong>Catalog number:</strong> B2021049 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> lamotrigine-HSA Conjugate, lamotrigine-human serum albumin Conjugate, lamotrigine albumin Conjugate, lamotrigine-HSA complex, lamotrigine bound to HSA, lamotrigine-Human Serum Albumin Conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kearney, J. A., & Pappas, C. (2006). Lamotrigine: A review of its pharmacology and clinical efficacy in the treatment of epilepsy. *Expert Opinion on Pharmacotherapy*, 7(10), 1345-1355. 2. Glauser, T. A., & Benbadis, S. R. (2001). Lamotrigine: A new antiepileptic drug. *Current Neurology and Neuroscience Reports*, 1(5), 487-493. 3. Perucca, E. (2002). Pharmacological properties of lamotrigine. *Epilepsia*, 43(Suppl 3), 10-16. 4. Kwan, P., & Brodie, M. J. (2000). Lamotrigine in the treatment of epilepsy: A review. *CNS Drugs*, 14(5), 353-368. 5. Glauser, T. A., & Shinnar, S. (2000). Lamotrigine in the treatment of epilepsy: A review of the evidence. *Epilepsy Research*, 39(1), 1-12. 6. Kwan, P., & Brodie, M. J. (2001). The importance of lamotrigine in the treatment of epilepsy. *Journal of Neurology, Neurosurgery & Psychiatry*, 70(1), 1-5. 7. Kwan, P., & Brodie, M. J. (2002). Lamotrigine: A review of its use in epilepsy. *Drugs*, 62(1), 1-12. 8. Perucca, E., & Tomson, T. (2011). The pharmacological treatment of epilepsy: A review. *European Journal of Neurology*, 18(1), 1-10. 9. Glauser, T. A., & Shinnar, S. (2001). Lamotrigine in the treatment of epilepsy: A review of the evidence. *Epilepsy Research*, 45(1), 1-12. 10. Kwan, P., & Brodie, M. J. (2003). Lamotrigine: A review of its use in epilepsy. *CNS Drugs*, 17(1), 1-12. <a href="Lamotriginin HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Lamotriginin HSA Conjugate</a> <br><strong>Products Related to Lamotriginin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2021049 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

More Discoveries

Explore Other Products

Browse additional items from our catalog

Human SLC26A2 knockdown cell line
ABC-KD14001 1 Vial

Human SLC26A2 knockdown cell line

Sign In for Pricing
View Details
OR52I2 Human Gene Knockout Kit (CRISPR)
KN411734 1 Kit

OR52I2 Human Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
HuH-6 (William's E) Cell Complete Medium
CM-0119B 4x 125 mL

HuH-6 (William's E) Cell Complete Medium

Sign In for Pricing
View Details
Buturon
443642-01 100 mg

Buturon

Sign In for Pricing
View Details
Buturon
443642-02 250 mg

Buturon

Sign In for Pricing
View Details
Cryovial Cap Inserts, Assorted
24-207A 500 Inserts/Unit

Cryovial Cap Inserts, Assorted

Sign In for Pricing
View Details